-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Aging Mice Share Features of Brain Network Decline with Humans
The human brain operates as a network of interconnected modules specialized for tasks that become less specialized as people age—a breakdown associated with memory loss and...
-
STAT News – Biotech2 weeks agoNIH grant terminations affected women scientists more than men, study finds
Academics have long referred to their field as a leaky pipeline — gradually bleeding researchers from marginalized communities as they progress through their careers. A new paper,...
-
Endpoints News2 weeks ago
Novartis to invest $480M in China following AstraZeneca and Lilly pledges
Novartis is the latest drugmaker to invest in its Chinese footprint, with a pledge of more than 3.3 billion yuan ($480 million) to bolster two manufacturing...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: The intersection of ‘Apprentice’ and the No Surprises Act
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Spring break is here, and our family is road tripping to...
-
Biotech Industry Intelligence2 weeks ago
FDA posts photos of Indian drugmaking facility cited in warning letter
FDA posts photos of Indian drugmaking facility cited in warning letter
-
Fierce Biotech2 weeks ago
Aardvark halts trials of obesity candidate, putting entire pipeline on pause
The voluntary pause comes less than a month after Aardvark paused a phase 3 trial for a related asset due to cardiac concerns.
-
BioPharma Dive – AI / Data2 weeks agoApogee strengthens case for longer-lasting eczema drug
Company shares climbed by more than 20% on Phase 2 study results suggesting the therapy could provide sustained relief when administered once every three or six...
-
BioPharma Dive – AI / Data2 weeks agoPfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
The partners said the shot produced “clinically meaningful” efficacy despite missing its main study objective, a finding they blamed on a lower-than-expected rate of infections during...
-
Uncategorized2 weeks ago
Tang Seizes Control of Aurinia, Taking CEO Post in Total Transformation of C-Suite
Healthcare investor Kevin Tang and his allies now hold almost every leadership position at Aurinia Pharmaceuticals, the company at the heart of former CDER Director George...
-
Biotech Industry Intelligence2 weeks ago
WuXi AppTec’s bet on the US pays off as revenues dip elsewhere
WuXi AppTec’s bet on the US pays off as revenues dip elsewhere
High-Throughput Platform for Fast-Acting Covalent Protein Therapies
Terns rebuffed a higher bid before selling to Merck
